{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:55:53Z","timestamp":1765040153306},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s11938-005-0014-z","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T14:42:27Z","timestamp":1180881747000},"page":"223-228","source":"Crossref","is-referenced-by-count":22,"title":["The role of antibiotics in inflammatory bowel disease"],"prefix":"10.1007","volume":"8","author":[{"given":"Chandrashekhar","family":"Thukral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Win J.","family":"Travassos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Peppercorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.gtc.2004.02.006","volume":"33","author":"KL Isaacs","year":"2004","unstructured":"Isaacs KL, Sartor RB: Treatment of inflammatory bowel disease with antibiotics. Gastroenterol Clin North Am 2004, 33: 335\u2013345. A comprehensive review of therapeutic uses of antibiotics in inflammatory bowel disease.","journal-title":"Gastroenterol Clin North Am"},{"key":"14_CR2","first-page":"9","volume":"4","author":"JH Cummings","year":"2003","unstructured":"Cummings JH, Macfarlane GT, Macfarlane S: Intestinal bacteria and ulcerative colitis. Curr Issues Intest Microbiol 2003, 4: 9\u201320.","journal-title":"Curr Issues Intest Microbiol"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","volume":"126","author":"RB Sartor","year":"2004","unstructured":"Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126: 1620\u20131633.","journal-title":"Gastroenterology"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/gast.2002.30294","volume":"122","author":"A Swidsinki","year":"2002","unstructured":"Swidsinki A, Ladhoff A, Pernthaelr A, et al.: Mucosal flora in inflammatory bowel disease. Gastroenterology 2002, 122: 44\u201354.","journal-title":"Gastroenterology"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1572-0241.2002.05613.x","volume":"97","author":"C Neut","year":"2002","unstructured":"Neut C, Bulois P, Desreumaux P, et al.: Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn\u2019s disease. Am J Gastoenterol 2002, 97: 939\u2013946.","journal-title":"Am J Gastoenterol"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.1995.tb03836.x","volume":"102","author":"R Duchman","year":"1995","unstructured":"Duchman R, Kaiser I, Hermann E, et al.: Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995, 102: 448\u2013455.","journal-title":"Clin Exp Immunol"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1053\/gast.2002.32415","volume":"122","author":"AP Cuthbert","year":"2002","unstructured":"Cuthbert AP, Fisher SA, Mirza MM, et al.: The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002, 122: 867\u2013874.","journal-title":"Gastroenterology"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK: Inflammatory Bowel Disease. N Engl J Med 2002, 347: 417\u2013429.","journal-title":"N Engl J Med"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00054725-199712000-00009","volume":"3","author":"B Feagan","year":"1997","unstructured":"Feagan B: Antibiotics are not effective therapy for Crohn\u2019s disease. Inflamm Bowel Dis 1997, 3: 314\u2013317.","journal-title":"Inflamm Bowel Dis"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00054725-200405000-00021","volume":"10","author":"GR Greenberg","year":"2004","unstructured":"Greenberg GR: Antibiotics should be used as first line therapy for Crohn\u2019s disease. Inflamm Bowel Dis 2004, 10: 318\u2013320.","journal-title":"Inflamm Bowel Dis"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/gut.32.9.1071","volume":"32","author":"L Sutherland","year":"1991","unstructured":"Sutherland L, Singleton J, Sessions J, et al.: Double blind placebo controlled trial of Metronidazole in Crohn\u2019s disease. Gut 1991, 32: 1071\u20131075.","journal-title":"Gut"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0016-5085(82)80189-3","volume":"83","author":"B Ursing","year":"1982","unstructured":"Ursing B, Alm T, Barany F, et al.: A comparative study of metronidazole and sulfasalazine for active Crohn\u2019s disease: the cooperative Crohn\u2019s disease study in Sweden. II Result. Gastroenterology 1982, 83: 550\u2013562.","journal-title":"Gastroenterology"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1572-0241.1999.935_q.x","volume":"94","author":"JF Colombel","year":"1999","unstructured":"Colombel JF, Lemann M, Cassagnou M, et al.: A controlled trial comparing ciprofloxacin and mesalamine for the treatment of active Crohn\u2019s disease. Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Am J Gastroenterol 1999, 94: 674\u2013678.","journal-title":"Am J Gastroenterol"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00054725-200201000-00002","volume":"8","author":"GL Arnold","year":"2002","unstructured":"Arnold GL, Beaves MR, Pryjdun VO, et al.: Preliminary study of ciprofloxacin in active Crohn\u2019s disease. Inflamm Bowel Disease 2002, 8: 10\u201315.","journal-title":"Inflamm Bowel Disease"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1155\/1998\/349460","volume":"12","author":"SL Greenbloom","year":"1998","unstructured":"Greenbloom SL, Steinhart AH, Greenberg GR: Combination ciprofloxacin and metronidazole for active Crohn\u2019s disease. Can J Gastroenterol 1998, 12: 53\u201356.","journal-title":"Can J Gastroenterol"},{"key":"14_CR16","first-page":"602","volume":"30","author":"C Prantera","year":"1998","unstructured":"Prantera C, Berto E, Scribano ML, et al.: Use of antibiotics in the treatment of active Crohn\u2019s disease: experience with metronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol 1998, 30: 602\u2013606.","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0016-5085(95)27989-X","volume":"108","author":"AH Steinhart","year":"1995","unstructured":"Steinhart AH, Feagan BG, Wong CJ, et al.: Combined budesonide and antibiotic therapy for active Crohn\u2019s disease: a randomized controlled trial. Gastroenterology 1995, 108: 1617\u20131621.","journal-title":"Gastroenterology"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-2036.2000.00753.x","volume":"14","author":"K Leiper","year":"2000","unstructured":"Leiper K, Morris AI, Rhodes JM: Open label trial of oral clarithromycin in active Crohn\u2019s disease. Aliment Pharmacol Ther 2000, 14: 801\u2013806.","journal-title":"Aliment Pharmacol Ther"},{"key":"14_CR19","first-page":"S250","volume":"98","author":"I Shafran","year":"2003","unstructured":"Shafran I, Johnson LK, Hamm L, et al.: Efficacy and tolerability of rifaximin, a nonabsorbed oral antibiotic in the treatment of active Crohn\u2019s disease: results of an open label study (abstr). Gastroenterol 2003, 98: S250.","journal-title":"Gastroenterol"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5085(82)80332-6","volume":"83","author":"LJ Brandt","year":"1982","unstructured":"Brandt LJ, Bernstein LH, Boley SJ, et al.: Metronidazole therapy for perineal Crohn\u2019s disease: a follow up study. Gastroenterology 1982, 83: 383\u2013387.","journal-title":"Gastroenterology"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0016-5085(95)90121-3","volume":"108","author":"P Rutgeerts","year":"1995","unstructured":"Rutgeerts P, Hiele M, Geboes K, et al.: Controlled trial of metronidazole treatment for prevention of Crohn\u2019s recurrence after ileal resection. Gastroenterology 1995, 108: 1617\u20131621.","journal-title":"Gastroenterology"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1572-0241.2000.01842.x","volume":"95","author":"MR Borgaonkar","year":"2000","unstructured":"Borgaonkar MR, Macintosh DG, Fardy JM: A metaanalysis of antimycobacterial therapy for Crohn\u2019s disease. Am J Gastroenterol 2000, 95: 725\u2013729.","journal-title":"Am J Gastroenterol"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","volume":"126","author":"EV Loftus","year":"2004","unstructured":"Loftus EV: Clinical epidemiology of inflammatory bowel disease: Incidence, prevalance and environmental influences. Gastroenterology 2004, 126: 1504\u20131517.","journal-title":"Gastroenterology"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00004836-198708000-00011","volume":"9","author":"T Gilat","year":"1987","unstructured":"Gilat T, Suissa A, Leichtman G, et al.: A comparative study of metronidazole and sulfasalazine in active, not severe, ulcerative colitis. J Clin Gastroenterol 1987, 9: 415\u2013417.","journal-title":"J Clin Gastroenterol"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00004836-200107000-00023","volume":"33","author":"E Parlak","year":"2001","unstructured":"Parlak E, Dagli U, Ulker A, et al.: Comparison of 5-amino salicylic acid plus glucocorticoid with metronidazole and ciprofloxacin in patients with active ulcerative colitis. J Clin Gastroenterol 2001, 33: 85\u201386.","journal-title":"J Clin Gastroenterol"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2036.1990.tb00456.x","volume":"4","author":"DA Burke","year":"1990","unstructured":"Burke DA, Axon AT, Clayden SA: The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther 1990, 4: 123\u2013129.","journal-title":"Aliment Pharmacol Ther"},{"key":"14_CR27","first-page":"282","volume":"117","author":"U Turunen","year":"1999","unstructured":"Turunen U, Farkkila Valtonen V: Long-term treatment of ulcerative colitis with ciprofloxacin. Gastroenterology 1999, 117: 282\u2013283.","journal-title":"Gastroenterology"},{"key":"14_CR28","first-page":"454","volume":"92","author":"GJ Mantzaris","year":"1997","unstructured":"Mantzaris GJ, Archavlis E, Christoforidis P, et al.: A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. Am J Gastroenterol 1997, 92: 454\u2013456.","journal-title":"Am J Gastroenterol"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1023\/A:1026648812439","volume":"44","author":"P Gionchetti","year":"1999","unstructured":"Gionchetti P, Rizzello F, Ferrieri A, et al.: Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: A double-blind, placebo-controlled trial. Dig Diseases and Sciences 1999, 44: 1220\u20131221.","journal-title":"Dig Diseases and Sciences"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/gut.27.10.1210","volume":"27","author":"RW Chapman","year":"1986","unstructured":"Chapman RW, Selsby WS, Jewell DP: Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986, 27: 1210\u20131212.","journal-title":"Gut"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/003655201750305503","volume":"9","author":"GJ Mantzaris","year":"2001","unstructured":"Mantzaris GJ, Petraki K, Archavlis E, et al.: A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute severe ulcerative colitis. Scand J Gastroenterol 2001, 9: 971\u2013974.","journal-title":"Scand J Gastroenterol"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/bega.2002.0343","volume":"17","author":"P Dunckley","year":"2003","unstructured":"Dunckley P, Jewell D: Management of acute severe colitis. Best Pract Res Clin Gastroenterol 2003, 17: 89\u2013103.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"14_CR33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.gtc.2004.02.005","volume":"33","author":"JC Chang","year":"2004","unstructured":"Chang JC, Cohen RD: Medical management of severe ulcerative colitis. Gastroenterol Clin North Am 2004, 33: 235\u2013240. Excellent review of management options for severe ulcerative colitis.","journal-title":"Gastroenterol Clin North Am"},{"key":"14_CR34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00004836-199307000-00005","volume":"17","author":"MA Peppercorn","year":"1993","unstructured":"Peppercorn MA: Are antibiotics useful in the management of nontoxic severe ulcerative colitis? J Clin Gastroenterol 1993, 17: 14\u201317.","journal-title":"J Clin Gastroenterol"},{"key":"14_CR35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/bega.2002.0348","volume":"17","author":"P Gionchetti","year":"2003","unstructured":"Gionchetti P, Amadini C, Rizello F, et al.: Diagnosis and treatment of pouchitis. Best Prac Res Clin Gastroenterol 2003, 17: 75\u201387.","journal-title":"Best Prac Res Clin Gastroenterol"},{"key":"14_CR36","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/BF02093783","volume":"39","author":"MV Madden","year":"1994","unstructured":"Madden MV, McIntyre AS, Nicholls RJ: Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994, 39: 1193\u20131196.","journal-title":"Dig Dis Sci"},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00054725-200111000-00004","volume":"7","author":"B Shen","year":"2001","unstructured":"Shen B, Achkar JP, Lashner BA, et al.: A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001, 7: 301\u2013305.","journal-title":"Inflamm Bowel Dis"},{"key":"14_CR38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00054725-199712000-00010","volume":"3","author":"MA Peppercorn","year":"1997","unstructured":"Peppercorn MA: Antibiotics are effective therapy for Crohn\u2019s disease: Inflamm Bowel Dis 1997, 3: 318\u2013319.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-005-0014-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-005-0014-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-005-0014-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:44:24Z","timestamp":1587577464000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-005-0014-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11938-005-0014-z","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}